Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M YATES

Showing results (541-550 of 554) with videos related to

Pageof 56
Sort By:
The Canadian Journal of Cardiology|January 29, 2013
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adultTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2023
Positive allosteric modulators of the α7 nicotinic acetylcholine receptor: SAR investigation around PNU-120596Brad A Acker, Valentina O Badescu, Mitchell B Berkenpas, et al.
Molecular Cancer Therapeutics|August 20, 2015
Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2Bryan D Smith, Michael D Kaufman, Cynthia B Leary, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|July 19, 2011
Clinical medical sciences for undergraduate dental students in the United Kingdom and Ireland - a curriculumA J Mighell, P A Atkin, K Webster, et al.
Science Immunology|November 1, 2024
The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cellsGerone A Gonzales, Song Huang, Liam Wilkinson, et al.
Nature Medicine|April 21, 2015
Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory diseaseMyriam Chimen, Helen M McGettrick, Bonita Apta, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
JMIR Research Protocols|May 21, 2021
Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled TrialAnna M Hood, Heather Strong, Cara Nwankwo, et al.
European Journal of Human Genetics : EJHG|January 13, 2021
Comprehensive study of 28 individuals with SIN3A-related disorder underscoring the associated mild cognitive and distinctive facial phenotypeMeena Balasubramanian, Alexander J M Dingemans, Shadi Albaba, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationshipDonn G Wishka, Daniel P Walker, Karen M Yates, et al.
Pageof 56

Showing results (541-550 of 554) with videos related to

Sort By:
Pageof 56
The Canadian Journal of Cardiology|January 29, 2013
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adultTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2023
Positive allosteric modulators of the α7 nicotinic acetylcholine receptor: SAR investigation around PNU-120596Brad A Acker, Valentina O Badescu, Mitchell B Berkenpas, et al.
Molecular Cancer Therapeutics|August 20, 2015
Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2Bryan D Smith, Michael D Kaufman, Cynthia B Leary, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|July 19, 2011
Clinical medical sciences for undergraduate dental students in the United Kingdom and Ireland - a curriculumA J Mighell, P A Atkin, K Webster, et al.
Science Immunology|November 1, 2024
The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cellsGerone A Gonzales, Song Huang, Liam Wilkinson, et al.
Nature Medicine|April 21, 2015
Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory diseaseMyriam Chimen, Helen M McGettrick, Bonita Apta, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
JMIR Research Protocols|May 21, 2021
Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled TrialAnna M Hood, Heather Strong, Cara Nwankwo, et al.
European Journal of Human Genetics : EJHG|January 13, 2021
Comprehensive study of 28 individuals with SIN3A-related disorder underscoring the associated mild cognitive and distinctive facial phenotypeMeena Balasubramanian, Alexander J M Dingemans, Shadi Albaba, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationshipDonn G Wishka, Daniel P Walker, Karen M Yates, et al.
Pageof 56